• 1
    Centers for Disease Control and Prevention. Cholera outbreak in Haiti. Morb Mortal Wkly Rep 2010; 59:1411.
  • 2
    Piarroux R, Barrais R, Faucher B, et al. Understanding the cholera epidemic, Haiti. Emerg Infect Dis 2011; 17:11611167.
  • 3
    Dowell SF, Braden CR. Implications of the introduction of cholera to Haiti. Emerg Infect Dis 2011; 17:12991300.
  • 4
    Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; 18th informational supplement. CLSI Document M100–S18, 2008.
  • 5
    Weinke T, Liebold I, Burchard GD, et al. Prophylactic immunisation against traveller's diarrhoea caused by enterotoxin-forming strains of Escherichia coli and against cholera: does it make sense and for whom? Travel Med Infect Dis 2008; 6:362367.
  • 6
    Steffen R, Acar J, Walker E, Zuckerman J. Cholera assessing the risk to travellers and identifying methods of protection. Travel Med Infect Dis 2003; 1:8088.
  • 7
    Al Abri SS, Beeching NJ, Nye FJ. Traveller's diarrhoea. Lancet Infect Dis 2005; 5:349360.
  • 8
    Freeman LD, Hooper DR, Lathen DF, et al. Brief prophylaxis with doxycycline for the prevention of traveler's diarrhoea. Gastroenterology 1983; 84:276280.
  • 9
    Guévart E, Noeske E, Sollé J, et al. Large-scale selective antibiotic prophylaxis during the 2004 cholera outbreak in Douala (Cameroun). Sante 2007; 17:6368.
  • 10
    Dromigny JA, Rakoto-Alson O, Rajaonatahina D, et al. Emergence and rapid spread of tetracycline-resistant Vibrio cholerae strains, Madagascar. Emerg Infect Dis 2002; 8:336338.
  • 11
    Taneja N, Samanta P, Mishra A, Sharma M. Emergence of tetracycline resistance in Vibrio cholerae O1 biotype El Tor serotype Ogawa from north India. Indian J Pathol Microbiol 2010; 53:865866.
  • 12
    World Health Organization. Guidelines for cholera control. Geneva: World Health Organization, 1993.
  • 13
    Guévart E, Solle J, Mouangue A, et al. Antibiotic susceptibility of Vibrio cholerae O1: evolution after prolonged curative and preventive use during the 2004 cholera epidemics in Douala (Cameroon). Med Mal Infect 2006; 36:329334.
  • 14
    Reveiz L, Chapman E, Ramon-Pardo P, et al. Chemoprophylaxis in contacts of patients with cholera: systematic review and meta-analysis. PloS One 2011; 6:e27060.